Navigation Links
Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints
Date:6/18/2013

CHAPEL HILL, N.C., June 18, 2013 /PRNewswire/ -- Recent regulatory and budget challenges have made it more and more difficult for Medical Education groups at large pharmaceutical companies to effectively educate doctors and other healthcare practitioners on the safe and effective use of their new products. With the pressure to reduce budgets mounting within the pharma industry, it is crucial that these "Med Ed" groups find practical, economical methods of reaching healthcare professionals.

To address the changes that are transforming the Medical Education area throughout the healthcare landscape, research and consulting firm Best Practices, LLC developed the critical new study "Benchmarking Critical Program Trends Transforming the Medical Device and Biopharmaceutical Marketplace." This field research investigates emerging trends regarding funding, delivery channels, program effectiveness, and value drivers related to the Medical Education function.

Key study topics include:

  • Funding channels utilized by Medical Education groups
  • Effectiveness of different Medical Education program types and delivery channels
  • Use of multi-disciplinary Medical Education programs
  • Trends in grants to professional societies/associations for accredited and non-accredited education programs 
  • Rating of company professionals most valued by physicians for education
  • Future trends in Medical Education programs and technology

The full 120-page report contains over 500 valuable benchmark metrics that will equip executives with the critical data needed to make informed decisions. The study identifies current program and funding trends that will allow Medical Education leadership to evaluate their organization's resource levels relative to other market leaders.

This benchmarking research drew participation from 32 Medical Education executives and managers from 31 leading global pharmaceutical and medical device companies. In addition, deep-dive interviews were conducted with five selected respondents to gather additional insights.

To learn more about this report, download a complimentary report excerpt by visiting http://www.best-in-class.com/rr1218.htm. For more information on other recent primary research studies, contact us at 919.403.0251, or visit our website at http://www.best-in-class.com/. Check out our new blog at http://whybenchmarking.com/ for more industry trends and topics!

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

 

 

 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
2. TMG Health To Present Kip Piper at Thought Leadership Dinner
3. GDS Internationals Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
4. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
5. Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
6. Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer
7. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
8. Though Over One-Third of Rheumatologists Have Prescribed Xeljanz for Their Rheumatoid Arthritis Patients, Physicians are Still Concerned With the Drugs Limited Post-Marketing Experience and Risks of Infection and Malignancy
9. In Pretreated Advanced Renal Cell Carcinoma, Thought Leaders Opinions and Clinical Data Indicate that Tivopath Has Efficacy and Tolerability Advantages Over Currently Used Therapies
10. For Osteoporosis and Osteopenia, Clinical Data and Thought Leaders Opinions Indicate that AMG-785/CDP-7851 and Odanacatib Have Advantages Over Alendronate
11. In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... NEW YORK , Dec. 5, 2016 Special ... collection of samples such as fluid and cells from organs ... advanced features, shapes, and sizes. The global market for special ... increasing geriatric population. In terms of revenue, the global special ... of 7.4% during the forecast period (2016–2026) and is expected ...
(Date:12/5/2016)... THE WOODLANDS, Texas , Dec. 5, 2016 /PRNewswire/ ... ) announced top-line results today from a Phase 2 ... inhibitor, conducted by Lexicon in collaboration with JDRF, the ... The purpose of this Phase 2 clinical trial, ... assess the effects of a once-daily 400 mg dose ...
(Date:12/5/2016)... 5, 2016 According to a new market ... Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, ... market is projected to reach USD 779.8 Million by 2021 from ... during the forecast period of 2016 to 2021. ... ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... ... measurement firms. The ranking is based on reported data for 2015 performance ... health systems, ambulatory surgical centers, clinically integrated networks, and many of the nation’s ...
(Date:12/6/2016)... ... December 06, 2016 , ... The NALA, a boutique marketing ... Bear Cancer Foundation (TBCF), a nonprofit 501(C)(3) organization providing financial and emotional support ... Obispo counties. To assist TBCF, the NALA recently hosted a Thanksgiving food drive that ...
(Date:12/6/2016)... ... December 06, 2016 , ... Healthcare leaders from ... regulations at the 7th annual Health IT Leadership Summit, to be held Wed., ... for the Centers for Medicare & Medicaid Services (CMS), will be the morning ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... is proud to announce it has added CXC Solutions (CXC) as a new ... These solutions are tailored to help benefits advisors reduce operating costs and ...
(Date:12/6/2016)... ... December 06, 2016 , ... Experimentation involving ... and development, largely due to its potential for revolutionizing human disease treatment. There ... human induced pluripotent stem cells (hiPSCs). , Both platforms have distinct advantages ...
Breaking Medicine News(10 mins):